Search / 7 posts tagged Biotech Investors

Roundup, Life Sciences, Alliances Rebecca Zacks wrote: Lots of news from the bigger players (think Genzyme and Biogen Idec) in the Boston-area life sciences arena last week, plus a peep here and there from the startups.

Roundup, deals, VC Rebecca Zacks wrote: I’m running out of “green” jokes to use in headlines describing the steady march of cash toward Evergreen Solar’s coffers. The latest example of that, plus a surprising number and variety of venture financings and other deals for one summer week, below.

Biotech, deals, VC Rebecca Zacks wrote: Peptimmune has finished an $8.9 million second close of its Series D financing, the Cambridge, MA-based firm announced today. The funding, led by New Enterprise Associates, MPM Capital, Hunt Ventures, Boston Medical Investors, and Silicon Valley Bank Capital, will be used to further development of Peptimmune’s treatment for multiple sclerosis.

“Frankenfoods” Gain Greater Acceptance as Food Prices Skyrocket Money Morning Writes: By Jason Simpkins Associate Editor For more than a decade, European policymakers have spurned genetically modified crops, but these so-called Frankenfoods are beginning to look more and more appetizing in the wake of food shortages and soaring prices.

Biotech, Investors, acquisitions Rebecca Zacks wrote: Millennium Pharmaceuticals. Sirtris Pharmaceuticals. Maybe Biogen Idec (or maybe not). Will CombinatoRx (NASDAQ:CRXX) be next on the list of Cambridge, MA, biotech firms scooped up by a Big Pharma buyer?

Back in December, my friend Steve Sjuggerud described a British spending spree taking place in America. At the time, the pound was worth about $1.95, and Brits were enjoying a 50% discount on their Christmas shopping across the pond.

Back in December, my friend Steve Sjuggerud described a British spending spree taking place in America. (more…) Related ArticlesHow to Sell What Big Pharma Will Pay Any Price to BuyGlobal Investing Roundups Wednesday, April 16th, 2008Your Next Car Made in China?Things are Getting Really Bad, Latte